home / stock / cdxs / cdxs quote
Last: | $2.89 |
---|---|
Change Percent: | 0.0% |
Open: | $2.99 |
Close: | $2.89 |
High: | $3 |
Low: | $2.8 |
Volume: | 233,026 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.89 | $2.99 | $2.89 | $3 | $2.8 | 233,026 | 07-02-2024 |
$2.99 | $3.11 | $2.99 | $3.11 | $2.95 | 385,388 | 07-01-2024 |
$3.1 | $3.05 | $3.1 | $3.2 | $3 | 1,201,222 | 06-28-2024 |
$3.01 | $3.17 | $3.01 | $3.17 | $2.98 | 314,786 | 06-27-2024 |
$3.18 | $2.91 | $3.18 | $3.22 | $2.86 | 566,082 | 06-26-2024 |
$2.9 | $2.98 | $2.9 | $3.01 | $2.8501 | 262,034 | 06-25-2024 |
$3 | $2.96 | $3 | $3.03 | $2.92 | 277,196 | 06-24-2024 |
$2.94 | $2.81 | $2.94 | $2.97 | $2.795 | 782,139 | 06-21-2024 |
$2.81 | $2.76 | $2.81 | $2.82 | $2.72 | 358,147 | 06-20-2024 |
$2.73 | $2.97 | $2.73 | $2.97 | $2.72 | 398,584 | 06-19-2024 |
$2.73 | $2.97 | $2.73 | $2.97 | $2.72 | 398,584 | 06-18-2024 |
$2.98 | $3.05 | $2.98 | $3.105 | $2.935 | 525,863 | 06-17-2024 |
$3.05 | $3.09 | $3.05 | $3.126 | $3.04 | 159,452 | 06-14-2024 |
$3.14 | $3.29 | $3.14 | $3.3399 | $3.09 | 316,354 | 06-13-2024 |
$3.3 | $3.54 | $3.3 | $3.54 | $3.28 | 222,640 | 06-12-2024 |
$3.32 | $3.25 | $3.32 | $3.32 | $3.17 | 232,215 | 06-11-2024 |
$3.28 | $3.2 | $3.28 | $3.38 | $3.16 | 298,456 | 06-10-2024 |
$3.26 | $3.45 | $3.26 | $3.49 | $3.23 | 450,735 | 06-07-2024 |
$3.52 | $3.81 | $3.52 | $3.825 | $3.51 | 420,258 | 06-06-2024 |
$3.85 | $3.55 | $3.85 | $3.88 | $3.47 | 565,405 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an asset purchase agreement with Crosswalk Therapeutics for the Company’s investigational Fabry and Pompe disease compounds. Under...
2024-05-30 07:30:04 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for CDXS on May 30, 2024 06:15AM ET. CDXS was trading at $3.19 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy rec...
2024-05-30 07:00:11 ET Kristen Kluska from Cantor Fitzgerald issued a price target of $11.00 for CDXS on 2024-05-30 06:15:00. The adjusted price target was set to $11.00. At the time of the announcement, CDXS was trading at $3.19. CDXS currently trades -34.90% versus its...